Johnson & Johnson (NYSE:JNJ) declared a quarterly dividend on Thursday, October 19th, RTT News reports. Stockholders of record on Tuesday, November 28th will be given a dividend of 0.84 per share on Tuesday, December 12th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date of this dividend is Monday, November 27th.
Johnson & Johnson has increased its dividend by an average of 6.7% per year over the last three years and has increased its dividend annually for the last 54 consecutive years. Johnson & Johnson has a payout ratio of 46.2% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Johnson & Johnson to earn $7.84 per share next year, which means the company should continue to be able to cover its $3.36 annual dividend with an expected future payout ratio of 42.9%.
Johnson & Johnson (NYSE:JNJ) opened at 141.78 on Friday. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $144.35. The stock’s 50 day moving average is $135.26 and its 200-day moving average is $131.38. The company has a market cap of $380.54 billion, a P/E ratio of 24.66 and a beta of 0.78.
Johnson & Johnson (NYSE:JNJ) last released its earnings results on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.10. The company had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a return on equity of 27.68% and a net margin of 21.28%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.68 EPS. Analysts predict that Johnson & Johnson will post $7.28 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on JNJ shares. UBS AG reiterated a “buy” rating and set a $148.00 target price (up from $136.00) on shares of Johnson & Johnson in a research note on Wednesday, July 19th. Goldman Sachs Group, Inc. (The) cut Johnson & Johnson from a “neutral” rating to a “sell” rating and boosted their price objective for the company from $125.00 to $130.00 in a research note on Wednesday, September 20th. BMO Capital Markets restated a “buy” rating and issued a $145.00 price objective on shares of Johnson & Johnson in a research note on Friday, September 1st. Alembic Global Advisors cut Johnson & Johnson from a “neutral” rating to an “underweight” rating in a research note on Friday, July 21st. Finally, Morgan Stanley boosted their price objective on Johnson & Johnson from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Wednesday, July 5th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $143.70.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2017/10/29/johnson-johnson-to-issue-quarterly-dividend-of-0-84-jnj.html.
Institutional investors have recently made changes to their positions in the stock. Harding Loevner LP bought a new position in shares of Johnson & Johnson during the second quarter valued at approximately $106,000. IHT Wealth Management LLC raised its holdings in shares of Johnson & Johnson by 46.4% during the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after acquiring an additional 3,467 shares in the last quarter. Mountain Capital Investment Advisors Inc bought a new position in shares of Johnson & Johnson during the second quarter valued at approximately $124,000. Lenox Wealth Management Inc. raised its holdings in shares of Johnson & Johnson by 1.7% during the second quarter. Lenox Wealth Management Inc. now owns 1,457 shares of the company’s stock valued at $193,000 after acquiring an additional 24 shares in the last quarter. Finally, Intercontinental Wealth Advisors LLC bought a new position in shares of Johnson & Johnson during the second quarter valued at approximately $200,000. Institutional investors own 65.89% of the company’s stock.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.